Search results
Showing 8236 to 8250 of 9128 results
Discontinued Reference number: GID-TA10880
Pembrolizumab for adjuvant treatment of hepatocellular carcinoma [ID3994]
In development Reference number: GID-TA10895 Expected publication date: 29 October 2026
Discontinued Reference number: GID-TA10906
In development Reference number: GID-TAG388 Expected publication date: TBC
In development Reference number: GID-TAG406 Expected publication date: TBC
Lung cancer (non-small cell, advanced, inoperable) - liposomal cisplatin (with chemotherapy) [ID657]
Discontinued Reference number: GID-TAG496
Avelumab for previously treated platinum-resistant ovarian cancer [ID1497]
In development Reference number: GID-TA10404 Expected publication date: TBC
In development Reference number: GID-TA10483 Expected publication date: TBC
Discontinued Reference number: GID-TA10583
In development Reference number: GID-TA10607 Expected publication date: TBC
In development Reference number: GID-TA10747 Expected publication date: TBC
Ipatasertib with abiraterone and prednisone for hormone-relapsed metastatic prostate cancer [ID3889]
Discontinued Reference number: GID-TA10779
Discontinued Reference number: GID-TA10841
Discontinued Reference number: GID-TA10965